What they were paid
Inhibrx Biosciences Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,500 | $0 | $139,685 | $0 | $192,185 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Inhibrx Biosciences, Inc. DEF 14A filed April 23, 2026, accession 0002007919-26-000014, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Inhibrx Biosciences pays directors a $35,000 cash retainer and $139,685 in Stock Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair)
The rest of the Inhibrx Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Douglas G. Forsyth | Independent Director | $202,685 |
| Kimberly Manhard | Independent Director | $183,685 |
| Kristiina Vuori, M.D., Ph.D | Independent Director | $186,185 |
| Mark P. Lappe | Chair of the Board | $0 |
The full Inhibrx Biosciences compensation record
free company briefThis page is one director within Inhibrx Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat